stars 1 stars 2 stars 3

We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.

Menlo Therapeutics Inc. Questions

The Menlo Therapeutics Inc. annual revenue was $10 million in 2026.

Mutya Harsch is the Chief Legal Officer, General Counsel and Secretary of Menlo Therapeutics Inc..

1 people are employed at Menlo Therapeutics Inc..

Menlo Therapeutics Inc. is based in Redwood City, California.

The NAICS codes for Menlo Therapeutics Inc. are [32541, 5417, 541, 32, 3254, 325, 54].

The SIC codes for Menlo Therapeutics Inc. are [873, 87].

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Winter 2026 G2 Leader Mid Market Winter 2026 G2 Leader Small Business Winter 2026 G2 Most Implementable Winter 2026 G2 Best Est ROI Mid Market Winter 2026 G2 Leader Momentum Winter 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users